GlycoVaxyn
Schlieren, Zurich, Switzerland
About GlycoVaxyn
GlycoVaxyn AG, a vaccine biopharmaceutical company, develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology. It develops and produces immunogenic glycoprotein conjugates vaccines for a range of bacterial diseases, such as pneumococcal and nosocomial infections.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $34.3M
- Funding stage: M&A
- Last round: Grant (May 2010)
- Website: glycovaxyn.com
- Phone: +41447338585
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/glycovaxyn-2535818 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.